Minnie V. Baylor-Henry
Independent DirectorMs. Minnie V. Baylor-Henry, JD, R.Ph, Esq., has been an Independent Director of Apyx Medical Corporation since August 1, 2019. She was Independent Director of Paratek Pharmaceuticals, Inc since June 09, 2021 until September 21, 2023. She is an Independent Director of Lantheus Holdings, Inc. since March 1, 2022. Ms. Baylor-Henry is the President of B-Henry & Associates Since 2015. She has been Director of Massachusetts Eye and Ear Infirmary, Inc. Ms. Baylor-Henry has been Independent Director of scPharmaceuticals Inc. since July 2018. Prior to her work at B-Henry, she served as the Worldwide Vice-President for Regulatory Affairs at Johnson & Johnson (J&J) Medical Devices & Diagnostics. Prior to returning to J&J, she was a national Director in the government, regulatory, Capital Markets & risk practice at Deloitte & Touche, with a practice focus on regulatory life sciences, including medical devices, pharmaceuticals and consumer products. Prior to joining Deloitte & Touche, Ms. Baylor-Henry worked in several roles at J&J in the Pharmaceutical and Consumer Sectors. She began her J&J career at J&J Pharmaceutical Research & Development as a Senior Director for Regulatory Affairs. She was promoted to Vice President, U.S. Medical & Regulatory Affairs for McNeil Pediatrics, where she had responsibility for many medical, as well as regulatory, functions. Within the Consumer sector, Ms. Baylor-Henry was the global Vice President for OTC Regulatory Affairs for McNeil Consumer Healthcare. She is a Trustee for Howard University, as well as the Chair of the Board of Visitors for Howard University’s College of Pharmacy. She is also an Independent Director for Flame Biosciences. She is Member of the Board of Directors for Mass Eye & Ear Hospital and Dress for Success Boston. Before joining J&J, she worked for FDA from 1991-1999. During her career at FDA, she had many roles, most notably, FDA's National Health Fraud Coordinator and the Director of the Division of Drug Marketing, Advertising and Communications (DDMAC) from 1995-1999. She had been Independent Director of PolarityTE, Inc. since December 11, 2018 until September 01, 2021. As a leader in the life sciences regulatory field, Ms. Baylor-Henry served as President & Chair of the Board of Directors for the Drug Information Association. Ms. Baylor-Henry served as Chairman of the Board of Directors at Food and Drug Law Institute since January 2011 and served as its President and was its Director since January 2008. She has been a Director at The Partnership, Inc. since December 2013. She received her Pharmacy degree (B.S.) in Pharmacy from Howard University's College of Pharmacy and her Law degree (J.D.) from Catholic University's Columbus School of Law.
Positions
- Company NameApyx Medical CorporationStock CodeAPYXPositionIndependent DirectorColleagues
- CDCharles D. GoodwinPresident, CEO & Director
- SGStavros George VizirgianakisIndependent Non-Executive Chairman
- MCMatthew C. HillCFO, Treasurer & Secretary
- SDShawn D. RomanChief Operating Officer
- MCMoshe CitronowiczSenior Vice President
- DCDolores CataniaChief of Confidence
- LJLawrence J. WaldmanLead Independent Director
- WLWendy Lauren LevineIndependent Director
